Status:
TERMINATED
Fat Tolerance From Lipid Emulsion Infusion Packaged in Glass or Plastic
Lead Sponsor:
Beth Israel Deaconess Medical Center
Conditions:
Hypertriglyceridemia
Eligibility:
All Genders
2-10 years
Phase:
NA
Brief Summary
This will be a prospective, randomized trial to determine if differences exist in the tolerance of lipid injectable emulsions in the neonatal intensive care unit (NICU). Lipid injectable emulsions are...
Detailed Description
The study is a single-center (BIDMC), prospective, single-blinded, randomized controlled study involving neonatal ICU patients who will receive lipid injectable emulsion infusions as part of their nor...
Eligibility Criteria
Inclusion
- All patients who present to the neonatal intensive care unit at BIDMC who require intravenous nutritional support
Exclusion
- Any patients receiving intravenous steroids
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2007
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00278928
Start Date
January 1 2006
End Date
April 1 2007
Last Update
March 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215